Bamlanivimab (LY-Cov555) for the Treatment of Covid-19

Bamlanivimab was developed by Eli Lilly and Company. Credit: Eli Lilly and Company.



  • Bamlanivimab (LY-CoV555)
  • Bamlanivimab (LY-CoV555)
  • Bamlanivimab (LY-CoV555)